trending Market Intelligence /marketintelligence/en/news-insights/trending/ZECBKMj0cjQDadsAu7TBxw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

MGC Diagnostics to explore strategic options

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

Blog

COVID-19 Impact & Recovery: Investment Banking


MGC Diagnostics to explore strategic options

MGC Diagnostics Corp. said its board initiated a strategic review of the company's businesses and assets to explore ways to increase shareholder value.

The global medical technology company will "consider all reasonable options," Chairman Mark Sheffert said. A special committee comprising Sheffert, Vice Chairman Terry Bunge and director Hank Struik will oversee the review process, with investment banking firm Craig-Hallum Capital Group LLC as adviser.

The MGC board also approved a special cash dividend of 70 cents apiece on its outstanding common stock, payable Feb. 24 to all shareholders of record as of Feb. 10.